We are looking for 2 to 17 years old to join a trial to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderate to severe ulcerative colitis (including associated symptoms such as cramping, growth failure, abdominal pain, malnutrition and/or eye pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the GI research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to take part.
